Loading: 100%
Medtronic plc logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 84,000 (as per Q3 2015)no data available
Sector Medical Devices, HealthcareMedical Devices, Healthcareno data available
Ticker MDTno data available
Financial year endsFY ends End of Aprilno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 176472808896
datesClosing price (adj.)
13.10.201778.07
11.10.201778.24
04.10.201778.63
27.09.201777.38
20.09.201779.69
13.09.201781.45
06.09.201779.40
30.08.201779.39
23.08.201779.28
16.08.201784.10
09.08.201783.46
02.08.201782.71
26.07.201785.24
19.07.201785.15
12.07.201787.29
05.07.201788.38
27.06.201787.81
20.06.201787.84
13.06.201786.24
06.06.201785.05
30.05.201783.93
23.05.201783.68
16.05.201783.02
09.05.201782.42
02.05.201783.82
25.04.201780.87
18.04.201779.45
11.04.201779.27
04.04.201779.73
28.03.201779.85
21.03.201779.80
14.03.201781.18
07.03.201780.08
28.02.201779.60
21.02.201779.25
14.02.201775.80
07.02.201774.88
31.01.201774.79
24.01.201772.63
17.01.201774.59
10.01.201773.68
03.01.201769.46
27.12.201670.61
19.12.201671.48
12.12.201672.08
05.12.201670.09
28.11.201672.35
21.11.201678.80
14.11.201677.01
07.11.201682.09
31.10.201680.21
24.10.201681.46
17.10.201680.75
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
78.07n/a
Market Capitalisation
in million USD
77,992n/a
Enterprise Value
in million USD
75,670n/a
Common Shares Outstanding
as per Apr 25, 2014
998,999,125n/a
Preferred Shares Outstanding
as per Apr 25, 2014
n/a
Average Basic Shares Outstanding
TTM
990,325,000n/a
Average Diluted Shares Outstanding
TTM
1,002,325,000n/a
Index Membership
n/a
Business Summary
Medtronic PLC is a medical technology company. It primarily manufacture and sell device-based medical therapies. It operates in Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies and Diabetes segments.
no data available
Key Financials & Ratios (all figures TTM as per Jan 31, 2015, million USD, full statements further below)
Profit & Loss
Revenues 17,522n/a
Gross Profit 12,976n/a
Operating Income 5,089n/a
EBITDA 5,933n/a
Net Profit 3,124n/a
Balance Sheet
Cash and Cash Equivalents 31,148n/a
Receivables 3,568n/a
Total Current Assets 38,161n/a
PP&E 2,326n/a
Total Assets 55,233n/a
Accounts Payable 635n/a
Current Debt 2,185n/a
Total Current Liabilities 5,613n/a
Long-Term Debt 26,641n/a
Total Liabilities 35,060n/a
Total Equity 20,173n/a
Cash Flow
Depreciation & Amortisation 844n/a
Change in Working Capital 425n/a
Operating Cash Flow 4,318n/a
Net Change in PP&E and Intangibles -421n/a
Investing Cash Flow -2,368n/a
Dividends Paid -1,179n/a
Financing Cash Flow 14,081n/a
Total Change in Cash 15,927n/a
Free Cash Flow 5,281n/a
Profitability Ratios
Gross Margin 74.1%n/a
Operating Margin 29.0%n/a
Net Profit Margin 17.8%n/a
Return on Equity 15.5%n/a
Return on Assets 5.7%n/a
Per Share Figures
Basic EPS 3.15n/a
Diluted EPS 3.12n/a
Sales per Share 17.69n/a
Book Value per Share 20.37n/a
FCF per Share 5.33n/a
Dividends per Share 1.19n/a
Price Multiples
Price to Earnings Ratio 24.75n/a
Price to Sales Ratio 4.41n/a
Price to Book Value 3.83n/a
Price to Free Cash Flow 14.64n/a
Valuation Metrics
EV/EBITDA 12.75n/a
EV/Sales 4.32n/a
Book to Market Value 0.26n/a
Other Ratios
Current Ratio 679.9%n/a
Liabilities to Equity Ratio 173.8%n/a
Debt to Assets Ratio 52.2%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14
Revenue
13,515
14,599
15,392
15,508
16,184
16,590
17,005
Sales & Services Revenue
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
Cost of revenue
-3,446
-3,518
-3,582
-3,700
-3,889
-4,126
-4,333
Cost of Goods & Services
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
Gross Profit
10,069
11,081
11,810
11,808
12,295
12,464
12,672
Other Operating Income
0
0
0
0
0
0
0
Operating Expenses
-5,982
-6,507
-7,023
-7,238
-7,448
-7,586
-7,673
Selling, General & Administrative
-4,707
-5,152
-5,282
-5,427
-5,623
-5,698
-5,847
Selling & Marketing
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
Research & Development
-1,275
-1,355
-1,424
-1,472
-1,490
-1,557
-1,477
Depreciation & Amortization
0
0
-317
-339
-335
-331
-349
Provision For Doubtful Accounts
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
Operating Income (Loss)
4,087
4,574
4,787
4,570
4,847
4,878
4,999
Non-Operating Income (Loss)
-472
-579
-396
-388
-513
-259
-289
Interest Expense, net
-36
-183
-246
-278
-149
-151
-108
Interest Expense
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
-436
-396
-150
-110
-364
-108
-181
Pretax Income (Loss), Adjusted
3,615
3,995
4,391
4,182
4,334
4,619
4,710
Abnormal Gains (Losses)
-875
-1,555
-447
-518
-189
-368
-1,005
Acquired In-Process R&D
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
Pretax Income (Loss)
2,740
2,440
3,944
3,664
4,145
4,251
3,705
Income Tax (Expense) Benefit, net
-602
-370
-861
-609
-730
-784
-640
Current Income Tax
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
2,138
2,070
3,083
3,055
3,415
3,467
3,065
Net Extraordinary Gains (Losses)
0
0
16
41
202
0
0
Discontinued Operations
0
0
16
41
202
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
2,138
2,070
3,099
3,096
3,617
3,467
3,065
Minority Interest
0
0
0
0
0
0
0
Net Income
2,138
2,070
3,099
3,096
3,617
3,467
3,065
Preferred Dividends
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
2,138
2,070
3,099
3,096
3,617
3,467
3,065
Remarks
restated on Jun 29, 2010 n/a
calculated values,
restated on Jun 28, 2011 n/a
calculated values,
restated on Jun 26, 2012 n/a
calculated values,
restated on Jun 24, 2013 n/a
calculated values,
restated on Jun 20, 2014 n/a
calculated values,
restated on Jun 20, 2014 n/a
calculated values,
restated on Jun 20, 2014 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
1,676
3,775
2,428
9,350
11,130
14,241
Cash & Cash Equivalents
n/a
1,271
1,400
1,382
1,172
919
1,403
Short Term Investments
n/a
405
2,375
1,046
8,178
10,211
12,838
Accounts & Notes Receivable
n/a
3,123
3,335
3,761
3,808
3,727
3,811
Accounts Receivable, Net
n/a
3,123
3,335
3,761
3,808
3,727
3,811
Notes Receivable, Net
n/a
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
Inventories
n/a
1,426
1,481
1,619
1,800
1,712
1,725
Raw Materials
n/a
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
Other Short Term Assets
n/a
1,227
1,248
1,342
1,378
1,283
1,433
Prepaid Expenses
n/a
622
704
561
675
744
697
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
258
0
0
0
Deferred Tax Assets
n/a
605
544
523
703
539
736
Income Taxes Receivable
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
Total Current Assets
n/a
7,452
9,839
9,150
16,336
17,852
21,210
Property, Plant & Equipment, Net
n/a
2,279
2,421
2,488
2,473
2,490
2,392
Property, Plant & Equipment
n/a
0
0
0
0
0
6,439
Accumulated Depreciation
n/a
0
0
0
0
0
-4,047
Long Term Investments & Receivables
n/a
2,769
4,632
6,116
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
Other Long Term Assets
n/a
11,088
11,198
12,921
14,009
14,558
14,341
Intangible Assets
n/a
0
0
0
0
0
0
Goodwill
n/a
8,195
8,391
9,520
9,934
10,329
10,593
Other Intangible Assets
n/a
2,477
2,559
2,725
2,647
2,673
2,286
Prepaid Expense
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
314
176
232
300
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
416
248
362
1,252
1,324
1,162
Total Noncurrent Assets
n/a
16,136
18,251
21,525
16,482
17,048
16,733
Total Assets
n/a
23,588
28,090
30,675
32,818
34,900
37,943
Liabilities and owners' equity
Payables & Accruals
n/a
1,413 1413000000
1,656 1656000000
1,419 1419000000
1,631 1631000000
1,780 1780000000
1,921 1921000000
Accounts Payable
n/a
382 382000000
420 420000000
495 495000000
565 565000000
681 681000000
742 742000000
Accrued Taxes
n/a
130 130000000
235 235000000
50 50000000
154 154000000
88 88000000
164 164000000
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
901 901000000
1,001 1001000000
874 874000000
912 912000000
1,011 1011000000
1,015 1015000000
Short Term Debt
n/a
522 522000000
2,575 2575000000
1,723 1723000000
3,274 3274000000
910 910000000
1,613 1613000000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
1,212 1212000000
890 890000000
1,584 1584000000
1,022 1022000000
1,260 1260000000
2,025 2025000000
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
7 7000000
14 14000000
16 16000000
19 19000000
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
1,212 1212000000
890 890000000
1,577 1577000000
1,008 1008000000
1,244 1244000000
2,006 2006000000
Total Current Liabilities
n/a
3,147 3147000000
5,121 5121000000
4,726 4726000000
5,927 5927000000
3,950 3950000000
5,559 5559000000
Long Term Debt
n/a
6,253 6253000000
6,944 6944000000
8,112 8112000000
7,359 7359000000
9,741 9741000000
10,315 10315000000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
1,006 1006000000
1,396 1396000000
1,869 1869000000
2,419 2419000000
2,538 2538000000
2,626 2626000000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
329 329000000
516 516000000
480 480000000
759 759000000
752 752000000
662 662000000
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
115 115000000
89 89000000
461 461000000
276 276000000
340 340000000
386 386000000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
562 562000000
791 791000000
928 928000000
1,384 1384000000
1,446 1446000000
1,578 1578000000
Total Noncurrent Liabilities
n/a
7,259 7259000000
8,340 8340000000
9,981 9981000000
9,778 9778000000
12,279 12279000000
12,941 12941000000
Total Liabilities
n/a
10,406 10406000000
13,461 13461000000
14,707 14707000000
15,705 15705000000
16,229 16229000000
18,500 18500000000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
112 112000000
110 110000000
107 107000000
104 104000000
102 102000000
100 100000000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
13,272 13272000000
14,826 14826000000
16,085 16085000000
17,482 17482000000
19,061 19061000000
19,940 19940000000
Other Equity
n/a
-202 -202000000
-307 -307000000
-224 -224000000
-473 -473000000
-492 -492000000
-597 -597000000
Equity Before Minority Interest
n/a
13,182 13182000000
14,629 14629000000
15,968 15968000000
17,113 17113000000
18,671 18671000000
19,443 19443000000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
13,182 13182000000
14,629 14629000000
15,968 15968000000
17,113 17113000000
18,671 18671000000
19,443 19443000000
Total Liabilities & Equity
n/a
23,588 23588000000
28,090 28090000000
30,675 30675000000
32,818 32818000000
34,900 34900000000
37,943 37943000000
Remarks restated on n/a restated on Jun 29, 2010 n/a restated on Jun 28, 2011 n/a restated on Jun 26, 2012 n/a restated on Jun 24, 2013 n/a restated on Jun 20, 2014 n/a restated on Feb 27, 2015 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14
Net Income/Starting Line
2,138
2,070
3,099
3,096
3,617
3,467
3,065
Net Income
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Depreciation & Amortization
637
699
772
804
833
819
850
Non-Cash Items
1,086
850
18
853
2
296
826
Stock-Based Compensation
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
Change in Working Capital
-372
259
242
-1,012
18
360
218
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
Cash from Operating Activities
3,489
3,878
4,131
3,741
4,470
4,942
4,959
Change in Fixed Assets & Intangibles
-606
-663
-635
-501
-484
-457
-396
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
Net Change in Long Term Investment
2,124
-115
-3,687
275
-1,987
-1,810
-2,784
Decrease in Long Term Investment
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-4,221
-1,624
-350
-1,332
-170
-820
-385
Net Cash from Divestitures
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
Other Investing Activities
-87
-338
-87
-176
-21
-14
-29
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
Cash from Investing Activities
-2,790
-2,740
-4,759
-1,734
-2,662
-3,101
-3,594
Dividends Paid
-565
-843
-907
-969
-1,021
-1,055
-1,116
Cash From (Repayment of) Debt
831
317
2,536
18
601
-26
1,431
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
-1,141
-343
-865
-1,055
-1,344
-980
-1,246
Increase in Capital Stock
0
0
0
0
0
0
0
Decrease in Capital Stock
0
0
0
0
0
0
0
Other Financing Activities
40
24
0
0
-118
-40
13
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
Cash from Financing Activities
-835
-845
764
-2,006
-1,882
-2,101
-918
Net Cash Before Disc. Operations and FX
-136
293
136
1
-74
-260
447
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
Net Cash Before FX
-136
293
136
1
-74
-260
447
Effect of Foreign Exchange Rates
-60
-82
-7
62
-71
7
37
Net Changes in Cash
-196
211
129
63
-145
-253
484
Remarks
restated on Jun 29, 2010 n/a
calculated values,
restated on Jun 28, 2011 n/a
calculated values,
restated on Jun 26, 2012 n/a
calculated values,
restated on Jun 24, 2013 n/a
calculated values,
restated on Jun 20, 2014 n/a
calculated values,
restated on Jun 20, 2014 n/a
calculated values,
restated on Jun 20, 2014 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo